DAVID KOCENDA: Open Payments
NPI 1124487665 · LAPEER, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,725 in 40 payments from 11 companies in 2025. Trend: 2023 $6,956 · 2024 $4,907 · 2025 $4,725
Speaker / faculty: $3,350Travel & lodging: $810Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $3,490 |
| Medtronic, Inc. | 15 | $908 |
| PFIZER INC. | 3 | $55 |
| Aucta Pharmaceuticals, Inc. | 4 | $53 |
| Neurocrine BioSciences, Inc. | 2 | $50 |
| Abbott Laboratories | 1 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| GENZYME CORPORATION | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $20 |
Products named: QULIPTA, INTERSTIM, NURTEC ODT, Motpoly XR, INGREZZA, INFINITY, KESIMPTA, UBRELVY.
Industry payments across MI — which companies pay providers there.
